Costa Rica Pharmaceutical Licensing

The General Health Law defines a pharmacy as premises for dispensing prescriptions and supplying medicines directly to the public; a droguería may import, store, distribute and wholesale but may not supply medicines directly to the public or dispense prescriptions; a pharmaceutical manufacturer/laboratory manufactures or handles medicines, raw materials exclusively for pharmaceutical manufacturing and cosmetics. The manufacture, handling, sale, supply and storage of medicines may take place only at authorised, registered and licensed pharmaceutical premises.

Natural persons and legal entities may apply. When applying to COLFAR, a legal entity must provide information on the entity, shareholders, board of directors and legal representative; this does not establish a uniform foreign ownership ratio, company-form requirement or minimum capital threshold. No such nationwide rules were verified in this review, and they should be confirmed separately during transaction structuring and local registration.

— Retail: a pharmacy supplies medicines directly to the public.

— Wholesale: a droguería imports, stores, distributes and wholesales.

— Manufacturing: a pharmaceutical manufacturer/laboratory manufactures or handles medicines.

Swipe horizontally to view all items

The Ministry of Health is responsible for establishment health permits/operating permits, product registration, and health oversight; COLFAR is responsible for the authorization and registration of private pharmaceutical establishments and regencia. The law requires establishments to obtain authorization and registration from COLFAR first, followed by registration with the Ministry of Health; each oversees matters within its respective jurisdiction.

The Inspection Committee within the Ministry of Health system controls the import, export, transit, purchase and sale, distribution, and storage of controlled drugs. Accordingly, an ordinary establishment permit is not an authorization for controlled drugs.

— Ministry of Health/DARS: establishment permits, product registration, and health inspections.

— COLFAR: authorization and professional registration of establishments and regencia.

— Inspection Committee: controlled-drug authorization.

A pharmacy is a legally recognized establishment that may dispense prescriptions and supply medicines directly to the public; it cannot be replaced by a wholesale warehouse, manufacturing plant, or general store. The Ministry of Health’s 2025 guide classifies community pharmacies as Risk B and specifies a 2-year operating permit.

The core application documents are the application form, a sworn declaration for an initial application or renewal, proof of identity, and proof of payment of the service fee; the guide also requires prior authorization and registration of regencia with COLFAR and an operating certificate. Community pharmacy standards require a technical director authorized by COLFAR and an authorized, duly qualified regente throughout all service hours.

Injections, vaccines, sterile/cytotoxic compounding, individualized dispensing, or controlled drugs entail dedicated spaces, procedures, or secure storage conditions; these should apply according to the actual scope of services and must not be generalized into a fixed floor-area requirement for all pharmacies.

— Risk category: Community pharmacy is Risk B.

— Personnel: A qualified regente must be present throughout all service hours.

— Expanded services: Provide additional conditions according to the services actually offered.

A droguería may import, store, distribute, and wholesale medicines; the law prohibits it from supplying medicines directly to the public or dispensing prescriptions. Anyone intending to engage in retail as well must separately meet the qualifications and premises requirements for a pharmacy.

The Ministry of Health guide classifies it as Risk B and requires an application form, applicable sworn declaration, proof of identity, proof of payment of the service fee, and COLFAR documents; it states that the operating permit is valid for 2 years. A droguería must implement Good Storage and Distribution Practices under Decree No. 37700-S.

Medicines must be stored using locations, conditions, equipment, procedures, packaging, and outer packaging that prevent deterioration or adulteration. Temperature control, transportation, retention samples, recalls, and other elements should be determined in accordance with current GxP requirements and the product scope.

— Permitted: Import, storage, distribution, and wholesale.

— Not permitted: Supplying medicines directly to the public or dispensing prescriptions.

— Ongoing requirements: A regente, a 2-year permit, and GxP for storage and distribution.

A pharmaceutical plant/pharmaceutical laboratory manufactures or handles medicines, raw materials intended exclusively for the manufacture of medicines, and cosmetics. The establishment permit, GMP compliance, and health registration for each marketed medicine are independent of one another and cannot substitute for one another.

The Ministry of Health’s 2025 guide classifies manufacturing as Risk A and lists an application form, applicable sworn declaration, proof of identity, proof of payment, and COLFAR documents; it also requires implementation of RTCA 11.03.42:07 GMP, published under Decree No. 38732-COMEX-MEIC-S. The guide states that the operating permit is valid for 2 years.

The law requires evidence that the premises, facilities, equipment, raw materials, and personnel are suitable, and that quality control requirements are strictly met. For biological products or injectables, evidence of testing for identity, potency, safety, and sterility, as well as relevant safety capabilities, is also required.

— Establishment: Risk A pharmaceutical plant operating permit.

— System: RTCA GMP and quality control.

— Product: Separate registration is required for each marketed medicine.

Except for statutory exceptions such as medicine cabinets and laboratories that manufacture only cosmetics without medicines, a pharmaceutical establishment must be under the technical and scientific direction of a pharmacist regente. The regente bears professional responsibility for the identity, purity, and good condition of medicines and for violations in their handling and sale; the owner bears joint liability.

A pharmacist may not serve as regente for multiple pharmaceutical establishments at the same time and must be present at the establishment during the hours stated in the certificate. Temporary absence requires prior written notice to COLFAR and arrangements for a substitute who will assume the responsibilities. Personal professional authorization is not equivalent to an establishment permit or product registration.

— Professional registration: COLFAR authorization for regencia.

— Presence: On-site during the approved hours.

— Substitute: Notify COLFAR in writing and arrange a substitute before leaving.

Pharmaceutical establishments must have the equipment needed for proper technical and professional operations and must use suitable locations, conditions, equipment, procedures, containers, and packaging to prevent medicines from deteriorating or being adulterated. Establishments must meet health and safety conditions; private pharmaceutical establishments must be separate from residential premises.

The pharmacy’s prescription-dispensing area and areas for medicines requiring regente supervision must be unavailable for service when the regente is absent. A community pharmacy must also have dedicated pharmacy space and areas for services, shelves, and storage; if it supplies controlled drugs, secure-storage requirements apply. Wholesale and manufacturing establishments must instead be designed in accordance with storage and distribution GxP and GMP, respectively.

— Common requirements: Equipment, health and safety, and controls to prevent deterioration or adulteration.

— Retail: Dedicated pharmacy space and areas arranged according to the services offered.

— Wholesale/manufacturing: Do not apply retail standards; follow GxP/GMP, respectively.

The statutory sequence is to first apply to COLFAR for establishment authorization and registration, then apply to the Ministry of Health for establishment registration and a health permit/operating permit. A COLFAR application must state at least the owner/legal entity’s details, establishment category and business hours, exact address, trade name, regente, and the regente’s working hours, and must be signed by the owner/legal representative and pharmacist.

For all 3 establishment categories, the Ministry of Health guide lists an application form, a sworn declaration using Annex 3 for an initial application or Annex 4 for a renewal, proof of identity, and proof of payment of the service fee. Initial applications or renewals must be submitted before operations begin to the local DARS, in person, by email with a digital signature, or online where available.

The actual business must also meet the applicable retail service standards, wholesale GxP, or manufacturing GMP requirements, as well as separate product registration, import, or controlled-drug documentation requirements.

— Determine the business type, establishment, and regente.

— Obtain COLFAR authorization and registration for the establishment/personnel.

— Submit the establishment application to the Ministry of Health through DARS.

— Complete product and cross-border/controlled-drug documentation separately.

Swipe horizontally to view all items

The Ministry of Health’s 2025 guide confirms that applications in all 3 categories must include proof of payment of the applicable risk-category service fee, and COLFAR also requires proof of payment of the operating fee. However, the public materials reviewed for this guide do not specify a current standard amount, applicable payment category, or local surcharges that can be applied directly; confirm these before submission.

A private pharmaceutical establishment permit is valid for 2 years; health registration of a medicine is usually valid for 5 years. The two must not be conflated. The 2022 announcement of reforms under Decree No. 43432-S mentioned a target of processing initial PSF applications for medium- and high-risk establishments in 1 day, but this is not a guaranteed processing time, an expedited right, or a promise of exemption from inspection for these 3 project types.

— Establishment permit: 2 years.

— Medicine product registration: Usually 5 years.

— Fees: Proof of payment is required; confirm the amount currently in effect.

Swipe horizontally to view all items

During operations, the establishment must maintain a regente, qualified equipment, health and safety conditions, and storage controls to prevent deterioration/adulteration. COLFAR and the Ministry of Health supervise within their respective areas of responsibility; the absence of a regente or non-compliance may result in closure, suspension, or cancellation.

Renewal should be sought within 60 calendar days before expiry, by applying separately to COLFAR for a new authorisation registration and to the Ministry of Health for a new two-year permit; if no application is made by the deadline, a new application must be submitted. Pharmacies, wholesalers, and manufacturers must also continue to comply respectively with service standards, GxP for storage and distribution, and GMP.

— Maintain the regente and replacement arrangements.

— Apply for renewal through both channels 60 days before expiry.

— Maintain applicable pharmacy standards, GxP, or GMP.

— Cooperate with inspections and retain quality records.

The owner must notify COLFAR at least 15 days in advance of termination of the regencia, a change in the legal entity's name, leave taken by the regente and replacement, relocation, closure, and sale of the establishment. COLFAR's current regencia form also lists opening, relocation, and changes to the owner/trade name/regente/hours as reasons for filing.

No rule was verified in this review providing for automatic transfer of the Ministry of Health establishment permit, COLFAR authorisation, regencia, or product registration following a share sale, change of control, or asset transaction. Before a transaction, obtain written confirmation of the filing, amendment, reapplication, inspection, and effective-date requirements for each specific structure.

— At least 15 days beforehand: notify of regencia, name, relocation, closure, sale of the establishment, and other matters.

— Assess changes to the owner, representative, address, hours, and product registration holder.

— Do not assume: a share transaction automatically transfers a permit.

Swipe horizontally to view all items

An establishment permit is not product marketing authorisation. Only medicines registered with the Ministry of Health and compliant with the applicable regulations may be imported, manufactured, handled, traded, or used. Product health registrations are generally valid for five years; changes to the name, formula, dosage form, packaging, labelling, or advertising require prior authorisation. Routine registration applications are submitted online through Regístrelo, and requirements vary by medicine category.

Import and distribution may be conducted only by natural or legal persons registered and authorised by COLFAR and registered with the Ministry of Health. Controlled narcotic drugs also require prior Ministry of Health authorisation, a relevant premises permit for a droguería/laboratory, valid product registration, a valid COLFAR pharmacist, an annual estimate/quota, and GxP/GMP; import, export, and transit also require an authorisation certificate from the Supervisory Board.

This review did not verify a comprehensive list of export permits applicable to all ordinary medicines and all destinations. Export requirements must be confirmed separately according to the product, destination, customs requirements, and whether the product is controlled; domestic registration or eligibility as an importer does not constitute automatic export authorisation.

— Product: registration is separate from the establishment permit.

— Import/distribution: requires eligible status of the entity and valid registration.

— Controlled drugs: require separate Ministry of Health authorisation and cross-border certificates from the Board.

— Individual professional authorisation: does not replace establishment, product, or cross-border permits.

Swipe horizontally to view all items